These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. SIMULTANEOUS ADMINISTRATION OF ORAL POLIO VACCINE AND GLOBULIN-MODIFIED ATTENUATED MEASLES-VIRUS VACCINE. FROESCHLE JE; CASEY H J Pediatr; 1965 Jun; 66():1031-4. PubMed ID: 14288455 [No Abstract] [Full Text] [Related]
26. [Follow-up studies 5 and a half years after measles vaccination in Basel]. Ritzel G; Just M Schweiz Med Wochenschr; 1972 Mar; 102(10):342. PubMed ID: 5034970 [No Abstract] [Full Text] [Related]
27. [Comparative results of anti-measles serological immunity after the disease and after vaccination]. Topciu V; Moldovan E; Csaky N; Băcilă E Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):671-5. PubMed ID: 5521121 [No Abstract] [Full Text] [Related]
28. Trend of measles morbidity in Thailand. Ariyasriwatana C J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S707-18. PubMed ID: 14700171 [TBL] [Abstract][Full Text] [Related]
29. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study. Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371 [TBL] [Abstract][Full Text] [Related]
31. [Clinical immunoserological study of combined innoculation of inactivated and live measles vaccines]. Yamazaki Y Nihon Shonika Gakkai Zasshi; 1969 May; 73(5):644-55. PubMed ID: 5817193 [No Abstract] [Full Text] [Related]
32. [Apropos of measles vaccination. Results of the first trials of antimeasles vaccination in France with hyperattenuated living virus vaccine]. Mande R; Jammet ML; Celers J; Boué A Ann Pediatr (Paris); 1967 Jan; 14(1):66-73. PubMed ID: 5597350 [No Abstract] [Full Text] [Related]
33. [Experience with preventive measles, mumps and rubella vaccination in unified Germany]. Gerike E; Tischer A Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543 [TBL] [Abstract][Full Text] [Related]
34. [Comparative studies of measles vaccines prepared from further attenuated strains Schwarz and SEVAC]. Adam E; Fosenbauerová E; Domorázková E; Kratochvílová M; Kubátová E; Mares I; Drevo M; Svandová E Cesk Pediatr; 1968 Jul; 23(7):581-93. PubMed ID: 5681931 [No Abstract] [Full Text] [Related]
35. Measles outbreak in an orphanage, Bangkok, Thailand, September-October 2000. Lertpiriyasuwat C; Kanlayanpotporn J; Deeying J; Kijphati R; Thepsoontorn S J Med Assoc Thai; 2002 Jun; 85(6):653-7. PubMed ID: 12322837 [TBL] [Abstract][Full Text] [Related]
36. [Trials of vaccination against measles with live and attenuated virus]. Albano A; De Donato S; Nodari R; Criscuolo A G Mal Infett Parassit; 1967 Oct; 19(10):631-8. PubMed ID: 5611500 [No Abstract] [Full Text] [Related]
37. Immune response to measles vaccine in Peruvian children. Bautista-López NL; Vaisberg A; Kanashiro R; Hernández H; Ward BJ Bull World Health Organ; 2001; 79(11):1038-46. PubMed ID: 11731811 [TBL] [Abstract][Full Text] [Related]
38. Optimal age for vaccinating Zimbabwean children against measles. 1. Maternal and transplacentally transmitted measles antibodies in infancy. Mhere OT; Mhlanga GE; Spencer HR Cent Afr J Med; 1984 Oct; 30(10):187-9. PubMed ID: 6518490 [No Abstract] [Full Text] [Related]
39. [On the effect of combined measles vaccination]. Ritzel G; Just M Schweiz Med Wochenschr; 1967 Apr; 97(13):405-6. PubMed ID: 5593611 [No Abstract] [Full Text] [Related]
40. A serological study of children vaccinated against measles. Strauss J; Zdrazílek J; Svandová E; Sejda J; Helcl J J Hyg Epidemiol Microbiol Immunol; 1969; 13(4):468-81. PubMed ID: 5391988 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]